Literature DB >> 25321415

Research Resource: STR DNA profile and gene expression comparisons of human BG-1 cells and a BG-1/MCF-7 clonal variant.

Yin Li1, Yukitomo Arao, Julie M Hall, Sandra Burkett, Liwen Liu, Kevin Gerrish, Vincent Cavailles, Kenneth S Korach.   

Abstract

Human ovarian cancer BG-1 cells are a valuable in vitro model that has enabled several laboratories to study the estrogenic responses of ovarian cancers. We recently discovered that there are two different BG-1 cell lines being used for experiments, denoted here as BG-1 FR and BG-1 NIEHS, which exhibit striking morphological differences. The objective of this study was to methodically analyze these two BG-1 variants and compare their characteristics. Short tandem repeat analysis revealed that the DNA profile of BG-1 FR cells was unique, yet the Short tandem repeat pattern of BG-1 NIEHS was identical with that of MCF-7 cells. From a cytogenetic analysis, it became apparent that the BG-1 FR line had the same profile as previously reported, whereas the BG-1 NIEHS and MCF-7 cells share a similar genetic display. A significant number of unique chromosomal translocations were observed between the BG-1 NIEHS and MCF-7 cells, suggesting that acquired genotypic differences resulted in the formation of two lines from a common origin. Although all cell types demonstrated a similar estrogen responsiveness in reporter gene assays, a microarray analysis revealed distinct estrogen-responsive gene expression patterns with surprisingly moderate to low overlap. We conclude that BG-1 FR is the original ovarian cancer cell line, whereas the BG-1 NIEHS is a variant from the MCF-7 cells. These findings provide much needed clarification of the identities and characteristics of key cell line models that are widely used to study estrogen action in female reproductive cancers.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25321415      PMCID: PMC4250366          DOI: 10.1210/me.2014-1229

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  48 in total

1.  Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse.

Authors:  J F Couse; J Lindzey; K Grandien; J A Gustafsson; K S Korach
Journal:  Endocrinology       Date:  1997-11       Impact factor: 4.736

2.  Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors.

Authors:  K R Geisinger; T E Kute; M J Pettenati; C E Welander; Y Dennard; L A Collins; M E Berens
Journal:  Cancer       Date:  1989-01-15       Impact factor: 6.860

Review 3.  Mechanisms of action and cross-talk between estrogen receptor and progesterone receptor pathways.

Authors:  B S Katzenellenbogen
Journal:  J Soc Gynecol Investig       Date:  2000 Jan-Feb

4.  Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence.

Authors:  M Berry; A M Nunez; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

5.  Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line.

Authors:  P Masiakowski; R Breathnach; J Bloch; F Gannon; A Krust; P Chambon
Journal:  Nucleic Acids Res       Date:  1982-12-20       Impact factor: 16.971

6.  Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells.

Authors:  Frederic Moll; Dionyssios Katsaros; Gwendal Lazennec; Nicolas Hellio; Pascal Roger; Pierre-Ludovic Giacalone; Dany Chalbos; Thierry Maudelonde; Henri Rochefort; Pascal Pujol
Journal:  Oncogene       Date:  2002-02-07       Impact factor: 9.867

Review 7.  Mechanisms of estrogen action.

Authors:  S Nilsson; S Mäkelä; E Treuter; M Tujague; J Thomsen; G Andersson; E Enmark; K Pettersson; M Warner; J A Gustafsson
Journal:  Physiol Rev       Date:  2001-10       Impact factor: 37.312

8.  Multiple mechanisms induce transcriptional silencing of a subset of genes, including oestrogen receptor alpha, in response to deacetylase inhibition by valproic acid and trichostatin A.

Authors:  George Reid; Raphaël Métivier; Chin-Yo Lin; Stefanie Denger; David Ibberson; Tomi Ivacevic; Heike Brand; Vladimir Benes; Edison T Liu; Frank Gannon
Journal:  Oncogene       Date:  2005-07-21       Impact factor: 9.867

9.  Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis.

Authors:  P Pujol; J M Rey; P Nirde; P Roger; M Gastaldi; F Laffargue; H Rochefort; T Maudelonde
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

Review 10.  Primary ovarian cancer chemotherapy: current standards of care.

Authors:  W P McGuire; M Markman
Journal:  Br J Cancer       Date:  2003-12       Impact factor: 7.640

View more
  9 in total

1.  Moving Toward Integrating Gene Expression Profiling Into High-Throughput Testing: A Gene Expression Biomarker Accurately Predicts Estrogen Receptor α Modulation in a Microarray Compendium.

Authors:  Natalia Ryan; Brian Chorley; Raymond R Tice; Richard Judson; J Christopher Corton
Journal:  Toxicol Sci       Date:  2016-02-10       Impact factor: 4.849

2.  Homogeneous pancreatic cancer spheroids mimic growth pattern of circulating tumor cell clusters and macrometastases: displaying heterogeneity and crater-like structure on inner layer.

Authors:  Hao Feng; Bao-Chi Ou; Jing-Kun Zhao; Shuai Yin; Ai-Guo Lu; Eva Oechsle; Wolfgang E Thasler
Journal:  J Cancer Res Clin Oncol       Date:  2017-05-11       Impact factor: 4.553

3.  Development of a recombinant human ovarian (BG1) cell line containing estrogen receptor α and β for improved detection of estrogenic/antiestrogenic chemicals.

Authors:  Jennifer C Brennan; Arzoo Bassal; Guochun He; Michael S Denison
Journal:  Environ Toxicol Chem       Date:  2015-12-09       Impact factor: 3.742

4.  Identification of nonmonotonic concentration-responses in Tox21 high-throughput screening estrogen receptor assays.

Authors:  Zhenzhen Shi; Menghang Xia; Shuo Xiao; Qiang Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2022-08-19       Impact factor: 4.460

5.  The Alginate Immobilization of Metabolic Enzymes Platform Retrofits an Estrogen Receptor Transactivation Assay With Metabolic Competence.

Authors:  Chad Deisenroth; Danica E DeGroot; Todd Zurlinden; Andrew Eicher; James McCord; Mi-Young Lee; Paul Carmichael; Russell S Thomas
Journal:  Toxicol Sci       Date:  2020-12-01       Impact factor: 4.849

6.  Genome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators.

Authors:  Georgette Moyle-Heyrman; Matthew J Schipma; Matthew Dean; David A Davis; Joanna E Burdette
Journal:  J Ovarian Res       Date:  2016-02-15       Impact factor: 4.234

7.  Effects of bisphenol compounds on the growth and epithelial mesenchymal transition of MCF-7 CV human breast cancer cells.

Authors:  Ji-Youn Kim; Ho-Gyu Choi; Hae-Miru Lee; Geum-A Lee; Kyung-A Hwang; Kyung-Chul Choi
Journal:  J Biomed Res       Date:  2017-07-13

8.  Treatment with Phytoestrogens Reversed Triclosan and Bisphenol A-Induced Anti-Apoptosis in Breast Cancer Cells.

Authors:  Geum-A Lee; Kyung-Chul Choi; Kyung-A Hwang
Journal:  Biomol Ther (Seoul)       Date:  2018-09-01       Impact factor: 4.634

9.  Differential in Vitro Biological Action, Coregulator Interactions, and Molecular Dynamic Analysis of Bisphenol A (BPA), BPAF, and BPS Ligand-ERα Complexes.

Authors:  Yin Li; Lalith Perera; Laurel A Coons; Katherine A Burns; J Tyler Ramsey; Katherine E Pelch; René Houtman; Rinie van Beuningen; Christina T Teng; Kenneth S Korach
Journal:  Environ Health Perspect       Date:  2018-01-31       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.